#Germany #Berlin #German Innovation #Ozelle #EHBT-50

Ozelle Wins Gold at German Innovation Awards

In a remarkable achievement, Ozelle has garnered the prestigious Gold Award at the German Innovation Awards for its cutting-edge EHBT-50 Mini Lab. This new generation analyzer has been recognized for its excellence in the field of hematology, showcasing significant user value, innovative engineering, and practical impact across various sectors.

The EHBT-50 Mini Lab is designed specifically for decentralized clinical environments, combining hematology testing with seven parameters, biochemistry, immunoassays, and AI-assisted morphological analysis in a single integrated diagnostic platform. This award highlights the system's ability to meet the growing demand for faster and more accessible diagnostics outside conventional centralized labs.

As diagnostic testing expands into frontline healthcare settings, laboratories face increasing pressures from staffing shortages, complex workflows, and tight turnaround times. Many distributed care settings still heavily rely on specialized personnel and centralized laboratory infrastructure for advanced morphological analysis. Ozelle's approach aims to streamline these workflows while maintaining laboratory-level analytical capabilities in everyday clinical practice.

The EHBT-50 Mini Lab utilizes Ozelle’s AI × CBM (Complete Blood Morphology) technology, which facilitates standardized morphological analysis and enables rapid identification of abnormal cells. By integrating AI-assisted interpretation with consistent cellular imaging, the system reduces reliance on highly specialized manual examinations in routine testing environments, enhancing consistency across different clinical contexts.

For daily clinical operations, the analyzer boasts a low-maintenance architecture, all-in-one sealed cartridges, room-temperature reagents, and one-click simplified testing that reduce operational complexity. The system also supports flexible analysis panels for applications such as infection assessment, diabetes management, and thyroid testing, thus assisting clinicians in managing a broader range of diagnostic needs without being dependent on multiple standalone analyzers.

Founded in Silicon Valley in 2014, Ozelle now operates globally, with a base in Frankfurt, and is committed to developing AI- and IoT-driven diagnostic systems for both medical and veterinary applications worldwide. "This recognition reflects the increasing interest in diagnostic systems that can reliably function in real-world clinical environments," stated Ozelle. "We believe hematology is entering a new phase where AI and morphological intelligence become further integrated into routine clinical workflows."

For those interested in witnessing the revolutionary potential of Ozelle’s AI-powered diagnostic solutions, personalized demonstrations are available. Contact Ozelle to learn more about transforming your clinical testing capabilities with innovative technology.



This award highlights Ozelle's commitment to addressing the evolving challenges in healthcare diagnostics, paving the way for enhanced efficiency and better patient outcomes.